Search Login Register
Asthenozoospermia
Summary
140
relevant articles (8 outcomes,
20 trials/studies)
found for this Disease
Description:
A condition in which the percentage of progressively motile sperm is abnormally low. In men, it is defined as <25% rapid motility or <50% progression in a semen sample (World Health Organization, 1992).
Key Drugs and Agents for Asthenozoospermia
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Kallikreins (Kallikrein)
:
3 outcomes 4 studies in 19 results
: IBA
-
Tamoxifen
:
1 outcome 1 study in 1 result
:
FDA 12
Generic
-
Clomiphene (Clomifene)
:
1 outcome in 3 results
:
FDA 4
Generic
-
Ketotifen (Ketotifene)
:
1 outcome in 1 result
:
FDA 5
-
Male Contraceptive Agents (Male Contraceptives)
:
1 outcome in 1 result
: IBA
-
royal jelly
:
1 outcome in 1 result
: IBA
-
Pentoxifylline (Trental)
:
3 studies in 7 results
:
FDA 11
Generic
-
Carnitine (L-Carnitine)
:
3 studies in 5 results
:
FDA 9
Generic
-
Testosterone (Sustanon)
:
2 studies in 6 results
:
FDA 12
Generic
-
Catalase
:
2 studies in 2 results
: IBA
Show All >>
Diseases Related to Asthenozoospermia
-
Oligospermia (Oligozoospermia)
-
Infertility (Sterility)
-
Azoospermia
-
Infection
-
Hearing Disorders (Hearing Disorder)
Show All >>
Key Therapies for Asthenozoospermia
Efficacy Chart >>
-
Aftercare (After-Treatment)
:
1 outcome in 5 results
-
Vasectomy (Vas Occlusion)
:
2 results
-
Massage (Reflexology)
:
1 result
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.